The Recall Desk
SevereFDA (Drugs)·D-0571-2018·Announced 2018-02-07

FDA Recalls MACA Gold Tablets Containing Unapproved Sildenafil

A&H Focal Inc. is recalling MACA gold tablets sold in New York and New Jersey because they contain sildenafil, an unapproved drug.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classified this as an FDA Class I recall, which mandates a severity score of at least 4 per the rubric.

Plain-English summary

A&H Focal Inc. is recalling MACA gold tablets, 6800 mg, 10-count bottles, which have labeling in a foreign language. The products were distributed in New York and New Jersey through six retail stores named "Asian Food Markets." All lots are affected.

The FDA determined that these products contain sildenafil, a drug approved by the FDA for the treatment of erectile dysfunction. Because the products were marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), they are considered unapproved drugs for which safety and efficacy have not been established.

Consumers who purchased these products should stop using them and return them to the place of purchase.

The recalled product

Product
MACA gold tablets, 6800 mg, 10-count bottle, labeling is in foreign language
Manufacturer
A&H Focal Inc.

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All Lots

Distribution

Distributed in 2 states:

Part of a larger recall action

This product is one of 21 recalled by A&H Focal Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 21 products in this recall →